BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1680782)

  • 1. [Comparative effect of anti-anginal drugs on myocardial ischemia in patient with effort angina: evaluation by ambulatory electrocardiographic monitoring].
    Suzuki Y
    Hokkaido Igaku Zasshi; 1991 Jul; 66(4):441-9. PubMed ID: 1680782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics and clinical significance of silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with ischemic heart disease].
    Tomita F
    Hokkaido Igaku Zasshi; 1990 Nov; 65(6):583-94. PubMed ID: 2265819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of various combination therapies in patients with coronary heart disease].
    Lehmann G; Reiniger G; Wolf H; Beyerle A; Rudolph W
    Herz; 1990 Dec; 15(6):399-409. PubMed ID: 1980660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effects of calcium antagonists in silent ischemia.
    Pepine CJ
    J Cardiovasc Pharmacol; 1990; 16 Suppl 2():S9-12. PubMed ID: 1369708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness and tolerability of bisoprolol vs. nifedipine in uremic patients with ischemic cardiopathy in dialysis treatment].
    Cice G; Di Benedetto A; Tagliamonte E; Ferrara L; Sorice P; Iacono A
    Cardiologia; 1997 Apr; 42(4):397-403. PubMed ID: 9244644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silent ischemia and beta-blockade.
    Egstrup K
    Circulation; 1991 Dec; 84(6 Suppl):VI84-92. PubMed ID: 1683614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV; Nedostup AV
    Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of symptomatic and asymptomatic myocardial ischemia using 120 mg delayed-action ISDN].
    Reiniger G; Lehmann G; Beyerle A; Wolf H; Rudolph W
    Herz; 1990 Aug; 15(4):259-65. PubMed ID: 2210597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Symptomatic and silent myocardial ischemia during drug therapy and after aortocoronary bypass].
    Meluzín J; Zeman K; Cerný J; Simek P; Julínek J
    Vnitr Lek; 1995 Nov; 41(11):739-43. PubMed ID: 8553591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of diltiazem in the treatment of silent myocardial ischemia.
    Waters D; Juneau M; Baird M; Klinke P; Warnica W; Chin C; Théroux P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S15-20. PubMed ID: 1725537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian variation of the total ischemic burden and influence by beta-blocking agents.
    Fox KM; Mulcahy DA
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S100-4. PubMed ID: 11527111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.
    Stone PH; Gibson RS; Glasser SP; DeWood MA; Parker JD; Kawanishi DT; Crawford MH; Messineo FC; Shook TL; Raby K
    Circulation; 1990 Dec; 82(6):1962-72. PubMed ID: 2122926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incremental doses of diltiazem in patients with coronary artery disease in end-stage renal failure maintained on hemodialysis: which is the optimal dose?].
    Cice G; Ferrara L; Tagliamonte E; Di Benedetto A; Iacono A
    Cardiologia; 1998 Dec; 43(12):1337-43. PubMed ID: 9988942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the sympathetic nervous system in the pathogenesis of chronic stable angina. Implications for the mechanism of action of beta-blockers.
    Chierchia S; Muiesan L; Davies A; Balasubramian V; Gerosa S; Raftery EB
    Circulation; 1990 Sep; 82(3 Suppl):II71-81. PubMed ID: 1975525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of beta-adrenergic blockade on the circadian rhythm of myocardial ischemia in ambulatory patients with stable angina.
    Prager G; Prager W; Hönig B
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):638-43. PubMed ID: 2471003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart rate, magnitude and duration of ST-segment depression in symptomatic and asymptomatic episodes of myocardial ischemia in patients with coronary artery disease recorded by Holter.
    Ilić S
    Acta Med Iugosl; 1989; 43(3):205-13. PubMed ID: 2741722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isosorbide dinitrate treatment of silent myocardial ischemia in patients after myocardial infarction].
    Moczurad KW; Dubiel JP; Grodecki JK; Curyło AM
    Przegl Lek; 1989; 46(3):350-5. PubMed ID: 2672115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts of silent myocardial ischemia.
    Bleske BE; Shea MJ
    Clin Pharm; 1990 May; 9(5):339-57. PubMed ID: 1972045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.